Breast Reconstruction Rates Stable After Increase From 2005 to 2012
FRIDAY, Dec. 13, 2024 -- Breast reconstruction (BR) rates increased from 2005 to 2012, then stabilized from 2013 to 2017, according to a study published online in the December issue of Plastic and Reconstructive Surgery.
Robyn N. Rubenstein, M.D., from the Memorial Sloan Kettering Cancer Center in New York City, and colleagues examined longitudinal trends in BR rates in the United States using data for mastectomy cases with and without BR from 2005 through 2017 abstracted from the National Surgical Quality Improvement Program database; the Surveillance, Epidemiology, and End Results Program database; and the National Cancer Database (NCDB). Predictors of reconstruction were identified, and race and insurance distributions were assessed over time.
The researchers found that 32.7 percent of 1,554,381 mastectomy patients underwent BR. From 2005 to 2012, there was an increase in the annual reconstruction rates per 1,000 mastectomies (incidence rate ratios, 1.077 for the National Surgical Quality Improvement Program; 1.090 for the Surveillance, Epidemiology, and End Results Program; and 1.092 for the NCDB); from 2013 to 2017, rates stabilized. The likelihood of undergoing BR was increased for patients who were younger (aged ≤59 years), privately insured, with fewer comorbidities, and who underwent contralateral prophylactic mastectomy. The increase in BR rates was higher among Black and Asian patients than White patients over time (252.3, 366.4, and 137.3 percent, respectively). BR rates increased more among Medicaid and Medicare patients compared with privately insured patients (418.6, 302.8, and 125.3 percent, respectively).
"We have demonstrated a stabilization in breast reconstruction rates over the past decade despite legislation to increase public awareness of access to breast reconstruction," the authors write. "Simultaneously, we observed a reduction in some historical health care disparities, including race and insurance type."
Several authors disclosed ties to the pharmaceutical and medical device industries.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Metabolic Surgery Has Greater Long-Term Benefits Than GLP-1 Receptor Agonists
WEDNESDAY, Oct. 1, 2025 -- People with obesity and type 2 diabetes who undergo metabolic surgery live longer and face fewer serious health problems compared with patients treated...
Elderly Patients Benefit From Screening Mammography
WEDNESDAY, Oct. 1, 2025 -- Patients with breast cancer diagnosed at 80 years of age or older who received screening mammography present with earlier-stage disease and have better...
Skipping First Mammogram Screening Increases Long-Term Breast Cancer Mortality Risk
WEDNESDAY, Oct. 1, 2025 -- Women who do not participate in their first eligible mammogram screening have a long-term risk for dying from breast cancer, according to a study...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.